GNAQ and uveal melanoma: Our data show that combined treatment of uveal melanoma cells with small molecule MEK and MET inhibitors simultaneously enhances the growth inhibitory effect of each agent in a GNAQ mutation-dependent manner, and yet the small molecule METi also served as a powerful blocker of migration in both GNAQ mutant and wild-type cells.